MAYNE PHARMA (OTCMKTS:MAYNF) Short Interest Decreased By 59.23%

February 15, 2018 - By Ellis Scott

The stock of MAYNE PHARMA (OTCMKTS:MAYNF) registered a decrease of 59.23% in short interest. MAYNF’s total short interest was 1.47M shares in February as published by FINRA. Its down 59.23% from 3.61 million shares, reported previously. With 63,900 shares average volume, it will take short sellers 23 days to cover their MAYNF’s short positions.

It closed at $0.53 lastly. It is down 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Mayne Pharma Group Limited manufactures and sells branded and generic pharmaceutical products worldwide. The company has market cap of $816.67 million. It operates through four divisions: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It has a 11.04 P/E ratio. The firm provides pharmaceuticals in the forms of tablets, capsules, foams, creams, powders, patches, pastes, and gels.

More recent Mayne Pharma Group Limited (OTCMKTS:MAYNF) news were published by: Fool.com.Au which released: “Why have Mayne Pharma Group Ltd shares performed so well in 2018?” on January 17, 2018. Also Fool.com.Au published the news titled: “Mayne Pharma Group Ltd share price tumbles 7%” on January 22, 2018. Reuters.com‘s news article titled: “UPDATE 2-Australia’s Mayne Pharma Group shares tumble on US lawsuit” with publication date: December 16, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.